Healthcare

CRT's Healthcare Investment Banking Group seeks to provide a full-range of corporate finance and advisory services to healthcare companies. Our approach is to build long-term partnerships with our clients and to provide customized, value-added solutions to the unique strategic, financial and scientific challenges healthcare companies face.

CRT's Healthcare Investment Banking Group is comprised of a dedicated team of investment banking professionals who bring an extensive knowledge of and experience within the healthcare industry to our transactions. Our healthcare care investment bankers are committed to delivering high-quality, personalized advice in a timely fashion to our clients.

CRT's healthcare investment bankers are supported by CRT's Sales & Trading and Research departments, as well as CRT BioMed, CRT's scientific advisory panel. Drawing upon CRT's distribution capabilities, our healthcare investment banking professionals are able to provide first rate capital markets execution for both new issues and secondary trading of virtually any security in a company's capital structure. CRT's top-to-bottom, value-oriented research philosophy identifies value opportunities throughout a company's capital structure, as well as provides prospective on emerging trends in the healthcare industry. CRT BioMed provides our healthcare investment bankers with the fundamental scientific analysis necessary to fully understand the underlying science driving our clients' businesses. CRT's Healthcare Investment Banking Group integrates all of CRT's resources to analyze the factors impacting our clients businesses and designs comprehensive solutions incorporating elements of capital markets, corporate finance and strategic advice.

Inquiries regarding CRT's healthcare investment banking capabilities should be directed to George Bickerstaff, Managing Director and Head of Healthcare Investment Banking.